Aortoiliac Aneurysms
12
0
0
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
8.3%
1 terminated out of 12 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
100%
7 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (12)
PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study
HORIZON CE Pivotal Study to Treat Abdominal Aortic Aneurysm
Zenith® Low Profile AAA Endovascular Graft
Evaluation of the GORE® EXCLUDER® Iliac Branch Endoprosthesis
PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation
PRESERVE-Zenith® Iliac Branch System Clinical Study
Zenith(R) Low Profile AAA Endovascular Graft Clinical Study
Zenith® Low Profile AAA Endovascular Graft
Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Zenith(R) Connection Endovascular Covered Stent Clinical Study
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study